Filtered By:
Countries: USA Health
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 11704 results found since Jan 2013.
Hospital Discharge and Readmissions Before and During the COVID-19 Pandemic for California Acute Stroke Inpatients
Stroke is a leading cause of death and disability in the United States, with approximately 795,000 new strokes occurring annually, including acute ischemic stroke (AIS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH).1 The Coronavirus Disease 2019 (COVID-19) pandemic has impacted all levels of care for stroke patients, such as delays in initial presentation, reduction in acute therapies, limitations of in-patient resources, delays or lack of initiation of secondary stroke prevention therapy, and limitations in rehabilitation services after hospital discharge.
Source: Journal of Stroke and Cerebrovascular Diseases - June 23, 2023 Category: Neurology Authors: George P. Albert, Daryl C. McHugh, Debra E. Roberts, Adam G. Kelly, Remi Okwechime, Robert G. Holloway, Benjamin P. George Source Type: research
Identification and comparison of pandemic-to-symptom networks of South Korea and the United States
ConclusionThe similar network structures and patterns observed in both countries imply that there may exist a stable relationship between the pandemic and internalizing symptoms above and beyond the sociocultural differences. The current findings provide new insights into the common potential pathway between the pandemic and internalizing symptoms in South Korea and in the U.S. and inform policymakers and mental health professionals of potential intervention targets to alleviate internalizing symptoms.
Source: Frontiers in Psychiatry - June 23, 2023 Category: Psychiatry Source Type: research
The Efficacy of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patients of African American and Hispanic Origin
The coronavirus disease 2019 (COVID-19) was first identified in December 2019 in Wuhan, China. It causes a severe acute respiratory syndrome, coronavirus 2 (SARS-CoV-2) and by early 2020 became a pandemic. The virus spread to Europe and then to the USA. The first case in the USA was identified in March 2020. According to the CDC, by the end of 2022, there were over 100 million documented cases of COVID-19 with more than 1 million (1,088,481) deaths in the United States.1 The virus mutates frequently and variants have developed with different transmissibility and ability to cause varying frequency of disease, hospitalization and death.
Source: The American Journal of Medicine - June 23, 2023 Category: General Medicine Authors: Nathan S. Bryan, Janos Molnar, John Somberg Tags: Clinical Research Study Source Type: research
Injury Patterns and Outcomes at a Single Pediatric Trauma Center During the COVID-19 Pandemic
The coronavirus disease 19 (COVID-19) pandemic is reported to have changed injury patterns, prevalence, and outcomes across multiple institutions in the United States. Interpretation of aggregate data is difficult because injury patterns vary between urban and rural hospitals and the implementation of locoregional public health policies and guidelines in response to COVID-19 differed. To prepare our trauma system for future societal shutdowns, we compared injury patterns and outcomes of injured children and adolescents at a single pediatric trauma center before and during the first two years of the COVID-19 pandemic.
Source: Journal of Surgical Research - June 22, 2023 Category: Surgery Authors: Travis M. Sullivan, Daniel Scheese, Eisha Jain, Zachary P. Milestone, Jeffrey Haynes, Laura A. Boomer Source Type: research
Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery
This study summarizes 195 clinical trials of advanced cell therapies targeting COVID-19 that were registered over the two years between January 2020 to December 2021. In addition, this work also analyzed the cell manufacturing and clinical delivery experience of 26 trials that published their outcomes by July 2022. Our demographic analysis found the highest number of cell therapy trials for COVID-19 was in United States, China, and Iran (N=53, 43, and 19, respectively), with the highest number per capita in Israel, Spain, Iran, Australia, and Sweden (N=0.641, 0.232, 0,223, 0.194, and 0.192 trials per million inhabitants). ...
Source: Frontiers in Immunology - June 21, 2023 Category: Allergy & Immunology Source Type: research
Contribution of wastewater-based epidemiology to SARS-CoV-2 screening in Brazil and the United States
J Water Health. 2023 Mar;21(3):343-353. doi: 10.2166/wh.2023.260.ABSTRACTWastewater-based epidemiology (WBE) is a valuable tool for investigating the existence, prevalence, and spread of pathogens, such as SARS-CoV-2, in a given population. WBE, proposed as part of the SARS-CoV-2 surveillance strategy for monitoring virus circulation, may complement clinical data and contribute to reducing the spread of the disease through early detection. In developing countries such as Brazil, where clinical data are scarce, information obtained from wastewater monitoring can be crucial for designing public health interventions. In the U...
Source: Journal of Water and Health - June 20, 2023 Category: Environmental Health Authors: Taciane Barbosa Henriques Servio T úlio Cassini Regina de Pinho Keller Source Type: research
The New War on Bad Air
A century ago, a well-ventilated building was considered good medicine. But by the time Covid-19 arrived, our buildings could barely breathe. How did that happen? And how do we let the fresh air back in?
Source: NYT Health - June 17, 2023 Category: Consumer Health News Authors: Emily Anthes Tags: your-feed-science your-feed-health Coronavirus (2019-nCoV) Heating, Ventilation and Cooling (HVAC) Workplace Environment Epidemics Wildfires Coronavirus Risks and Safety Concerns Centers for Disease Control and Prevention United States Source Type: news
Biden Says He Plans to Appoint Mandy Cohen as C.D.C. Director
Dr. Cohen will replace Dr. Rochelle P. Walensky, an infectious disease expert who has overseen the agency since the beginning of Mr. Biden ’s term and started a broad effort to reorganize it.
Source: NYT Health - June 16, 2023 Category: Consumer Health News Authors: Noah Weiland Tags: Cohen, Mandy K Centers for Disease Control and Prevention Appointments and Executive Changes Biden, Joseph R Jr United States Politics and Government Coronavirus (2019-nCoV) Walensky, Rochelle Source Type: news
